Wells Fargo’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-135,701
| Closed | -$452K | – | 7238 |
|
|
2019
Q4 | $452K | Buy |
135,701
+12,299
| +10% | +$39.1K | ﹤0.01% | 4451 |
|
|
2019
Q3 | $375K | Sell |
123,402
-6,800
| -5% | -$19.1K | ﹤0.01% | 4572 |
|
|
2019
Q2 | $310K | Sell |
130,202
-15,600
| -11% | -$46.6K | ﹤0.01% | 4706 |
|
|
2019
Q1 | $547K | Sell |
145,802
-4,998
| -3% | -$18.7K | ﹤0.01% | 4277 |
|
|
2018
Q4 | $542K | Buy |
150,800
+17,900
| +13% | +$77.8K | ﹤0.01% | 4281 |
|
|
2018
Q3 | $761K | Buy |
132,900
+32,013
| +32% | +$183K | ﹤0.01% | 4149 |
|
|
2018
Q2 | $506K | Buy |
100,887
+16,705
| +20% | +$86K | ﹤0.01% | 4444 |
|
|
2018
Q1 | $432K | Sell |
84,182
-12,919
| -13% | -$77.7K | ﹤0.01% | 4502 |
|
|
2017
Q4 | $584K | Buy |
97,101
+49,300
| +103% | +$297K | ﹤0.01% | 4282 |
|
|
2017
Q3 | $265K | Buy |
47,801
+45,201
| +1,739% | +$233K | ﹤0.01% | 4761 |
|
|
2017
Q2 | $12K | Hold |
2,600
| – | – | ﹤0.01% | 5744 |
|
|
2017
Q1 | $12K | Buy |
2,600
+2,100
| +420% | +$20.2K | ﹤0.01% | 5841 |
|
|
2016
Q4 | $6K | Sell |
500
-23
| -4% | -$216 | ﹤0.01% | 5929 |
|
|
2016
Q3 | $5K | Buy |
+523
| New | +$4.37K | ﹤0.01% | 5928 |
|
|
2016
Q2 | – | Sell |
-14,184
| Closed | -$86K | – | 6470 |
|
|
2016
Q1 | $86K | Sell |
14,184
-18,246
| -56% | -$118K | ﹤0.01% | 4946 |
|
|
2015
Q4 | $263K | Buy |
32,430
+17,441
| +116% | +$130K | ﹤0.01% | 4283 |
|
|
2015
Q3 | $110K | Buy |
14,989
+13,857
| +1,224% | +$141K | ﹤0.01% | 4814 |
|
|
2015
Q2 | $12K | Sell |
1,132
-2,008
| -64% | -$22.2K | ﹤0.01% | 5768 |
|
|
2015
Q1 | $29K | Buy |
+3,140
| New | +$28.1K | ﹤0.01% | 5240 |
|
Wells Fargo's FOMX Position: Q1 2020 in Review
Wells Fargo sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 135,701 shares — an estimated $452K sold.
Wells Fargo first reported a position in FOMX in Q1 2015 and held it in 19 quarters. The position peaked at $761K in Q3 2018. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.
- Wells Fargo reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
- Wells Fargo sold 135,701 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $452K.
- Wells Fargo first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2015 and held it in 19 quarters.
- Wells Fargo's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $761K in Q3 2018.
- 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.
Based on Wells Fargo's 13F filing for Q1 2020, filed 14 May 2020.